Shares of JB Chemicals & Pharmaceuticals Ltd. fell over 6% on Monday after Torrent Pharmaceuticals announced the acquisition of majority stake in the company.
Torrent Pharmaceuticals will acquire a controlling stake in JB Chemicals and Pharmaceuticals Ltd. from global investment firm KKR in a deal valued at Rs 25,689 crore on a fully diluted basis, the companies said on Sunday. The transaction includes an acquisition of a majority stake followed by a full merger of the two companies.
Torrent has signed definitive agreements to acquire 46.39% equity in JB Pharma at a price of Rs 1,600 per share in the first phase, translating to a transaction value of Rs 11,917 crore, according to a statement to the exchanges. The deal will then trigger a mandatory open offer for an additional 26% stake at a price of Rs 1,639.18 per share, the statement said.
Torrent has also said that it intends to acquire up to 2.80% of equity from certain JB Pharma employees at the same price as KKR, the statement added.
JB Chemicals & Pharmaceuticals Share Price
Shares of JB Chemicals & Pharmaceuticals fell as much as 6.71% to Rs 1,680.60 apiece. They pared losses to trade 6.53% lower at Rs 1,683.70 apiece, as of 9:35 a.m. This compares to a 0.1% decline in the NSE Nifty 50.
The stock has fallen 4.14% in the last 12 months and 9.13% year-to-date. Total traded volume so far in the day stood at 0.42 times its 30-day average. The relative strength index was at 66.08.
Out of 15 analysts tracking the company, 14 maintain a 'buy' rating and one recommends a 'hold', according to Bloomberg data. The average 12-month consensus price target implies an upside of 18.1%.
RECOMMENDED FOR YOU

Cohance Lifesciences Block Deal: Promoter Likely To Offload Rs 1,756-Crore Stake


Stock Market Today: All You Need To Know Going Into Trade On Sept. 10


Prime Focus Share Price Surges To Record High After Madhusudan Kela, Ramesh Damani Acquire Stake


Torrent Pharma Announces Open Offer To Acquire Rs 6,843-Crore Stake In JB Chemicals
